Waechtersbach, Germany

Peter Hölig


 

Average Co-Inventor Count = 6.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Hölig

Introduction

Peter Hölig is a notable inventor based in Waechtersbach, Germany. He has made significant contributions to the field of materials science and drug delivery systems. With a total of 3 patents to his name, Hölig's work has the potential to impact various medical applications.

Latest Patents

Hölig's latest patents include innovative technologies that address complex challenges. One of his patents focuses on "Masking and subsequently visualising ESR signals using the combination of two materials." This invention explores how a body with multiple phases can exhibit different electron spin resonance (ESR) spectra, which do not simply result from the combination of the ESR spectra of each individual phase. Another significant patent is for a "Delivery system for sustained release of a calcium-channel blocking agent." This system is designed for introduction into the cerebrospinal fluid of a subject and comprises a solid dispersion product of a calcium-channel blocking agent in a specific mixture of poly(lactide-co-glycolide) materials.

Career Highlights

Throughout his career, Peter Hölig has worked with reputable companies such as BDS Pharma GmbH and AbbVie Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in pharmaceutical technologies.

Collaborations

Hölig has collaborated with notable colleagues, including Bernd Liepold and Jörg Breitenbach. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Peter Hölig's contributions to innovation in materials science and drug delivery systems highlight his role as a significant inventor. His patents reflect a commitment to advancing technology for medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…